These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3820189)

  • 21. Characterisation of the humoral immune response during murine pregnancy.
    Dillon DM; Cunningham C; Melvin WT; Catto GR
    J Reprod Immunol; 1988 Oct; 14(1):59-72. PubMed ID: 3199391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of RT1 antigen differences in semi-allogeneic rat pregnancy.
    Power DA; Cunningham C; Catto GR
    Clin Sci (Lond); 1987 Jan; 72(1):37-45. PubMed ID: 3492325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rat model of pregnancy-induced sensitization to transplants.
    Qian Z; Liu J; Fox-Talbot K; Wasowska BA; Baldwin WM
    Transplant Proc; 2005; 37(1):96-7. PubMed ID: 15808559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal response to paternal trophoblast antigens.
    Mowbray J; Jalali R; Chaouat G; Clark DA; Underwood J; Allen WR; Mathias S
    Am J Reprod Immunol; 1997 Jun; 37(6):421-6. PubMed ID: 9228296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal alloimmune reactions towards the murine conceptus and graft-versus-host reaction (GVHR). II. Inhibition of priming by placental extracts.
    Voisin JE; Kinsky RG; Voisin GA
    J Reprod Immunol; 1986 Jul; 9(2):85-94. PubMed ID: 3746778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fetal bone grafts do not elicit allograft rejection because of protecting anti-Ia alloantibodies. Implications to the immune survival of fetuses in allogeneic mothers.
    Segal S; Siegal T; Altaraz H; Lev-El A; Nevo Z; Nebel L; Katzenelson A; Feldman M
    Transplantation; 1979 Aug; 28(2):88-95. PubMed ID: 384624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoregulatory effects of lymphokine-driven placental cells on cloned T cells in vitro.
    Mogil RJ; Wegmann TG
    Reg Immunol; 1988; 1(1):69-77. PubMed ID: 3275130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Species diversity in the immunogenetic relationship between mother and fetus: is trophoblast insusceptibility to immunological destruction the only essential common feature for the maintenance of allogeneic pregnancy?
    Billington WD
    Exp Clin Immunogenet; 1993; 10(2):73-84. PubMed ID: 8251182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major anti-paternal alloantibody induced by murine pregnancy is non-complement-fixing IgG1.
    Bell SC; Billington WD
    Nature; 1980 Nov; 288(5789):387-8. PubMed ID: 7432537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex-associated differences in the immune response against fetal major histocompatibility antigens.
    Tartakovsky B; De Baetselier P; Feldman M; Segal S
    Transplantation; 1981 Nov; 32(5):395-7. PubMed ID: 7036455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic cell populations in normal and alloimmunized pregnant mice.
    Smith G; Chappell F
    Immunology; 1984 May; 52(1):49-54. PubMed ID: 6715021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Enhancing antibodies and supressive cells in maternal anti-fetal immune reaction].
    Chaouat G; Voisin GA; Daëron M; Kanellopoulos J
    Ann Immunol (Paris); 1977; 128(1-2):21-4. PubMed ID: 848875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
    Ramos A; Merino R; Merino J
    Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoactive products of placenta. V: Soluble factors from murine placenta can block effector stages of maternal antipaternal cell-mediated immunity.
    Chaouat G; Kolb JP; Riviere M; Lankar D
    Am J Reprod Immunol Microbiol; 1986 Nov; 12(3):70-7. PubMed ID: 3492935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune tolerance induction using fetal directed placental injection in rodent models: a murine model.
    Takahashi K; Endo M; Miyoshi T; Tsuritani M; Shimazu Y; Hosoda H; Saga K; Tamai K; Flake AW; Yoshimatsu J; Kimura T
    PLoS One; 2015; 10(4):e0123712. PubMed ID: 25876079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histoincompatibility and maternal immunological status as determinants of fetoplacental weight and litter size in rodents.
    Beer AE; Scott JR; Billingham RE
    J Exp Med; 1975 Jul; 142(1):180-96. PubMed ID: 1097574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal anti-placental reactivity in natural, immunologically-mediated fetal resorptions.
    Tangri S; Wegmann TG; Lin H; Raghupathy R
    J Immunol; 1994 May; 152(10):4903-11. PubMed ID: 8176211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-fetal allo-antibody in the pregnant female.
    Bell SC; Billington WD
    Immunol Rev; 1983; 75():5-30. PubMed ID: 6354912
    [No Abstract]   [Full Text] [Related]  

  • 39. Specific maternal anti-fetal lymphoproliferative responses and their regulation by natural immunosuppressive factors.
    Hoskin DW; Murgita RA
    Clin Exp Immunol; 1989 May; 76(2):262-7. PubMed ID: 2474394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of gamma delta T lymphocytes at the maternal-fetal interface.
    Heyborne KD; Cranfill RL; Carding SR; Born WK; O'Brien RL
    J Immunol; 1992 Nov; 149(9):2872-8. PubMed ID: 1401918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.